Cctn- male sites - contraceptive efficacy clinical trial HHSN275201300025I/HHSN27500006

Active Awarded Last action

Contract number
HHSN27500006
Awardee
Awarding agency
Obligated
$7,686,827

Award facts

Contract value 100% obligated
$7,686,827.00 Current and potential, with all options
Completion date 99% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
Pricing
Cost No Fee
Place of performance
Seattle, WA 98195, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00009 · Nichd: R & D: clinical evaluation of NES TES GEL for male contraception: non-severable $0
Other Administrative Action P00008 $0
Funding Only Action P00007 $1,493,885
Funding Only Action P00006 $1,186,405
Other Administrative Action P00005 $0
Other Administrative Action P00004 $0
Supplemental Agreement for work within scope P00003 · Cctn male sites - UW task 6, clinical evaluation of NES TES GEL for male contraception, extend performance to 9/15/23 and add funds. $2,638,829
Supplemental Agreement for work within scope P00002 $0
Supplemental Agreement for work within scope 1 $0
Original award $2,367,708

About this award

The University of Washington was awarded a delivery order valued at $7.7 million under the National Institute of Child Health and Human Development (NICHD) Contraceptive Clinical Trials Network program. This non-set-aside contract, awarded September 14, 2015, with an ultimate completion date of December 31, 2026, supports clinical research evaluating the efficacy and safety of nestronone gel and testosterone gel as male contraceptive methods. The work will be performed at the University of Washington's Seattle campus through the Office of Sponsored Programs, which manages the institution's federal research contracts and grants.

This delivery order is a child contract under the broader NICHD Contraceptive Clinical Trials Network Indefinite Delivery Vehicle, which provides the programmatic framework for multi-site clinical evaluations. The research addresses a significant gap in male contraceptive options by investigating hormonal gel formulations as potential reversible contraceptive methods. As a cost-no-fee contract type, the University of Washington will be reimbursed for allowable costs incurred in conducting the clinical trials without profit margin, aligning with the federal government's approach to funding academic research institutions for non-commercial research initiatives.

Quick answers

Who was awarded contract HHSN27500006?

HHSN27500006 was awarded to University Of Washington by National Institute of Child Health and Human Development (National Institutes of Health) on September 14, 2015.

How much is contract HHSN27500006 worth?

The government has obligated $7,686,827 on HHSN27500006.

Is contract HHSN27500006 an order under another contract?

Yes. HHSN27500006 is a delivery order under HHSN275201300025I, an indefinite delivery contract, on NICHD Contraceptive Clinical Trials Network.

Was contract HHSN27500006 competed?

The extent of competition for HHSN27500006 was full and open competition. The government received 2 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award